Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares
ZEPP
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
Last trade$2.75
Day change+$0.21 (+8.27%)
Day range$2.46 – $2.79
Volume40,991
Market cap$37M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for ZEPP.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for ZEPP.
Recent news
Company coverage with links to the original publishers.
The global fitness tracker market is projected to grow from USD 71.2 billion in 2026 to USD 91.6 billion by 2033, with a CAGR of 3.70%. Growth is driven by AI-enabled wearables, rising health awareness, integration with healthcare platforms, and expanding adoption in emerging markets. Key opportunities exist in affordable devices, multifunctional wearables, and partnerships with healthcare and wellness providers.
Zepp Health, a health wearables company, experienced a dramatic stock surge of nearly 1,100% in six months, driven by strong Q2 and Q3 revenue growth and robust sales of Amazfit wearables, despite historical challenges.
Zepp Health has experienced significant growth in 2025, transitioning from Xiaomi-branded wearables to its own Amazfit brand, resulting in a 46% revenue increase and a 1,900% stock price surge.
The personalized retail nutrition and wellness market is expected to expand from $4.54 billion in 2025 to $16.25 billion by 2034, driven by increasing health awareness, technological advancements, and a shift towards holistic wellness approaches.
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.
Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.70 million.
Peraso shares tumbled 23.3% to $1.32 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers
Ontrak, Inc. (NASDAQ: OTRK) shares climbed 197.8% to $0.5660 ahead of the company's presentation at the 36th Annual Roth Conference.
Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) gained 97.3% to $20.99 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21.
SCWorx Corp. (NASDAQ: WORX) gained 74% to $3.22.
Spire Global, Inc. (NYSE: SPIR) climbed 50.7% to $18.50 after announcing a collaboration with NVIDIA to advance AI-driven weather prediction.
Enveric Biosciences, Inc (NASDAQ: ENVB) shares climbed 43.6% to $1.5801 after the company announced that it signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases.
Zoomcar Holdings, Inc. (NASDAQ: ZCAR) rose 33.1% to $1.57 after the company announced that it partnered with EaseMyTrip to integrate its cars within the travel platform.
Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 32% to $1.51 after the company announced pre-clinical research showcasing the potential of HT-ALZ in Alzheimer's disease.
Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 27.2% to $16.09. The company announced a $90 million private placement financing and provided pipeline updates.
National CineMedia, Inc. (NASDAQ: NCMI) gained 25.5% to $5.30 after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. The company said it sees first-quarter total revenue of $34.5 million to $35.5 million.
Alignment Healthcare, Inc. (NASDAQ: ALHC) gained 17.7% to $5.50.
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose 15% to $43.63 ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Mar 25, 2022
$0.40
Apr 15, 2022
special
Stock splits
Historical share-structure events and their execution dates.